126 related articles for article (PubMed ID: 37704215)
21. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA
J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182
[TBL] [Abstract][Full Text] [Related]
22. Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography.
Vis AN; Meijer D; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; Heymans MW; Nieuwenhuijzen JA; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Stricker P; Haynes AM; Oprea-Lager DE; Coughlin GD; van Leeuwen PJ
Eur Urol Oncol; 2023 Dec; 6(6):553-563. PubMed ID: 37045707
[TBL] [Abstract][Full Text] [Related]
23. Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
Walz J; Bladou F; Rousseau B; Laroche J; Salem N; Gravis G; Briganti A; Chun FK; Karakiewicz PI; Fournier G
Urology; 2012 Mar; 79(3):546-51. PubMed ID: 22386393
[TBL] [Abstract][Full Text] [Related]
24. A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals.
Bandini M; Marchioni M; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Shariat SF; Montorsi F; Saad F; Briganti A; Tilki D; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):449-456. PubMed ID: 29249688
[TBL] [Abstract][Full Text] [Related]
25. Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Hinev AI; Anakievski D; Kolev NH; Hadjiev VI
Urol Int; 2014; 92(3):300-5. PubMed ID: 24480972
[TBL] [Abstract][Full Text] [Related]
26. Development of a novel nomogram incorporating platelet-to-lymphocyte ratio for the prediction of lymph node involvement in prostate carcinoma.
Merhe A; Labban M; Hout M; Bustros G; Abou Heidar N; El-Asmar JM; Bulbul M; El Hajj A
Urol Oncol; 2020 Dec; 38(12):930.e1-930.e6. PubMed ID: 32736935
[TBL] [Abstract][Full Text] [Related]
27. Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms.
Lodeta B; Baric H; Hatz D; Jozipovic D; Augustin H
BMC Urol; 2023 Nov; 23(1):190. PubMed ID: 37980520
[TBL] [Abstract][Full Text] [Related]
28. Development and internal validation of a novel nomogram for predicting lymph node invasion for prostate cancer patients undergoing extended pelvic lymph node dissection.
Li Z; Huang Y; Zhao D; Luo X; Wu Z; Zheng X; Xie Y; Liu Y; Wu J; Peng Y; Li Y; Zhou F
Front Oncol; 2023; 13():1186319. PubMed ID: 37223684
[TBL] [Abstract][Full Text] [Related]
29. Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
Abdollah F; Schmitges J; Sun M; Thuret R; Djahangirian O; Tian Z; Shariat SF; Briganti A; Perrotte P; Montorsi F; Karakiewicz PI
Urology; 2011 Dec; 78(6):1363-7. PubMed ID: 22137704
[TBL] [Abstract][Full Text] [Related]
30. External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era.
Frego N; Paciotti M; Buffi NM; Maffei D; Contieri R; Avolio PP; Fasulo V; Uleri A; Lazzeri M; Hurle R; Saita A; Guazzoni GF; Casale P; Lughezzani G
Front Surg; 2022; 9():829515. PubMed ID: 35284478
[TBL] [Abstract][Full Text] [Related]
31. Decision curve analysis to compare 3 versions of Partin Tables to predict final pathologic stage.
Augustin H; Sun M; Isbarn H; Pummer K; Karakiewicz P
Urol Oncol; 2012; 30(4):396-401. PubMed ID: 20884254
[TBL] [Abstract][Full Text] [Related]
32. A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging.
Di Trapani E; Luzzago S; Peveri G; Catellani M; Ferro M; Cordima G; Mistretta FA; Bianchi R; Cozzi G; Alessi S; Matei DV; Bagnardi V; Petralia G; Musi G; De Cobelli O
Urol Oncol; 2021 Jul; 39(7):431.e15-431.e22. PubMed ID: 33423938
[TBL] [Abstract][Full Text] [Related]
33. Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a "Negative Core" in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis.
Leong JY; Herrera-Caceres JO; Goldberg H; Tham E; Teplitsky S; Gomella LG; Trabulsi EJ; Lallas CD; Fleshner NE; Tilki D; Chandrasekar T
Urology; 2020 Mar; 137():102-107. PubMed ID: 31705947
[TBL] [Abstract][Full Text] [Related]
34. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA
Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258
[TBL] [Abstract][Full Text] [Related]
35. External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Diamand R; Ploussard G; Roumiguié M; Oderda M; Benamran D; Fiard G; Quackels T; Assenmacher G; Simone G; Van Damme J; Malavaud B; Iselin C; Descotes JL; Roche JB; Peltier A; Roumeguère T; Albisinni S
Eur Urol; 2021 Feb; 79(2):180-185. PubMed ID: 33023770
[TBL] [Abstract][Full Text] [Related]
36. Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer.
Pellegrino F; Mazzone E; Stabile A; Beauval JB; Marra G; Campi R; Afferi L; Zhuang J; Sorce G; Rosiello G; Barletta F; Scuderi S; Guo H; Gontero P; Minervini A; Ploussard G; Montorsi F; Briganti A; Gandaglia G
Urol Oncol; 2023 Sep; 41(9):387.e17-387.e25. PubMed ID: 37198026
[TBL] [Abstract][Full Text] [Related]
37. Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection.
de Barros HA; Remmers S; Luiting HB; van Leenders GJLH; Roobol MJ; Bekers EM; Amin A; Haynes AM; Delprado W; Stricker PD; van der Poel HG; van der Kwast TH; van Leeuwen PJ
Urology; 2022 Oct; 168():156-164. PubMed ID: 35803346
[TBL] [Abstract][Full Text] [Related]
38. Development and external validation of a multivariable [
Muehlematter UJ; Schweiger L; Ferraro DA; Hermanns T; Maurer T; Heck MM; Rupp NJ; Eiber M; Rauscher I; Burger IA
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3137-3146. PubMed ID: 37261472
[TBL] [Abstract][Full Text] [Related]
39. Do prostate cancer nomograms give accurate information when applied to European patients?
Turo R; Forster JA; West RM; Prescott S; Paul AB; Cross WR
Scand J Urol; 2015 Feb; 49(1):16-24. PubMed ID: 24882277
[TBL] [Abstract][Full Text] [Related]
40. External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study.
Meijer D; van Leeuwen PJ; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Oprea-Lager DE; Coughlin GD; Vis AN
Eur Urol; 2021 Aug; 80(2):234-242. PubMed ID: 34024652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
